CIK 0001478320
- Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 270907024
- Phone
- +1 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- 4 Grant or award Principal Accounting Officer acquired 3,837 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at an average $34.98 ($349,800)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Scientific Officer sold 11,200 shares at an average $33.71 ($377,561)
- 4 Open-market sale Chief Operating Officer sold 3,125 shares at an average $33.16 ($103,630)
- 4 Open-market sale Chief Scientific Officer sold 11,685 shares at an average $32.95 ($385,018)
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at an average $32.41 ($324,050)
- 4 Open-market sale Chief Scientific Officer sold 11,685 shares at an average $36.98 ($432,054)
- 4 Open-market sale CEO and Chairman sold 43,499 shares at an average $38.43 ($1,671,496)
- 4 Open-market sale Chief Financial Officer sold 14,375 shares at an average $39.47 ($567,331)
- 4 Open-market sale SVP and General Counsel sold 495 shares at $40.00 ($19,800)
- 4 Open-market sale Director sold 14,916 shares at $35.00 ($522,060)
- 4 Open-market sale Chief Scientific Officer sold 11,685 shares at an average $34.25 ($400,231)
- 4 Grant or award Chief Commercial Officer acquired 97,213 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 15,000 shares at an average $34.07 ($511,049)
- 4 Open-market sale Chief Scientific Officer sold 11,685 shares at an average $37.47 ($437,885)
- 4 Open-market sale SVP, Diagnostics, T-Detect sold 651 shares at $36.12 ($23,514)
- 4 Open-market sale Director sold 2,500 shares at $36.80 ($92,000)
- 4 Open-market sale CEO and Chairman sold 1,501 shares at $38.24 ($57,398)
Page 11 of 28 · 544 filings